Early markers of occult megaloblastosis for low-cost detection of hyperhomocysteinemia in patients with ischaemic stroke: Preventive approach for primary health care

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 9, 2014, Pages 713-716

  Neogi, Sohini Sengupta ^a   Thomas, Monica ^a   Sharma, Archna ^a   Kumar, Jaishree ^a   Khanduri, Uma ^a  

^a ST STEPHEN S HOSPITAL   (India)

Author keywords

Cobalamin; Folate; Homocysteine; Hypersegmented neutrophils

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; BIOLOGICAL MARKER; CYANOCOBALAMIN;

ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMIC ASPECT; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MEGALOBLASTIC ANEMIA; NEUTROPHIL; PRIMARY HEALTH CARE; BLOOD; CEREBROVASCULAR ACCIDENT; COMPLICATION; EARLY DIAGNOSIS; ECONOMICS; METABOLISM;

ANEMIA, MEGALOBLASTIC; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; EARLY DIAGNOSIS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; NEUTROPHILS; PRIMARY HEALTH CARE; STROKE; VITAMIN B 12;

EID: 84919638886     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0096     Document Type: Article

References (39)

1. Allen, R.H., Stabler, S.P., Savage, D.G., and Lindenbaum, J. 1993. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J. 7: 1344–1353. PMID:7901104.
2. Antony, A.C. 2001. Prevalence of cobalamin (vitamin B12) and folate deficiency in India — audi altera partem. Am. J. Clin. Nutr. 74: 157–159. PMID:11470714.
3. Antony, A.C. 2003. Vegetarianism and vitamin B-12 (cobalamin) deficiency. Am. J. Clin. Nutr. 78: 3–6. PMID:12816765.
4. Bang, H., Mazumdar, M., and Spence, J.D. 2006. Tutorial in biostatistics: Analyzing associations between total plasma homocysteine and B vitamins using optimal categorization and segmented regression. Neuroepidemiology, 27: 188–200. doi:10.1159/000096149. PMID:17035715.
5. Bhargava, S., Ali, A., Manocha, A., Kankra, M., Das, S., and Srivastava, L.M. 2012a. Homocysteine in occlusive vascular disease: a risk marker or risk factor. Indian J. Biochem. Biophys. 49(6): 414–420. PMID:23350275.
6. Bhargava, S., Ali, A., Manocha, A., Kankra, M., Das, S., and Srivastava, L.M. 2012b. Lowering homocysteine and modifying nutritional status with folic acid and vitamin B(12) in Indian patients of vascular disease. J. Clin. Biochem. Nutr. 50(3): 222–226. doi:10.3164/jcbn.11-72. PMID:22573925.
7. Boushey, C.J., Beresford, S.A., Omenn, G.S., and Motulsky, A.G. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 274: 1049–1057. doi:10.1001/jama.274.13.1049. PMID:7563456.
8. Carmel, R., Green, R., Rosenblatt, D.S., and Watkins, D. 2003. Update on cobal-amin, folate, and homocysteine. Hematology Am. Soc. Hematol. Educ. Program, 1: 62–81. doi:10.1182/asheducation-2003.1.62. PMID:14633777.
9. Carmel, R., Mallidi, P.V., Vinarskly, S., Brar, S., and Frouhar, Z. 2012. Hyperho-mocystenermia and cobalamin deficiency in young Asian Indians in the United States. Am. J. Hematol. 70: 107–114. doi:10.1002/ajh.10093. PMID: 12111783.
10. Dalal, P.M., Bhattacharjee, M., Vairale, J., and Bhat, P. 2008. Mumbai stroke registry (2005–2006) — surveillance using WHO steps stroke instrument — challenges and opportunities. J. Assoc. Physicians India, 56: 675–680. PMID: 19086353.
11. den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briet, E., Reitsma, P.H., et al. 1996. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N. Engl. J. Med. 334: 759–762. doi:10.1056/NEJM199603213341203. PMID:8592549.
12. Fauci, A.S., Braunwald, E., Kasper, D.L., Hauser, S.L., Longo, D.L., Jameson, J.L., and Loscalzo, J. (Editors). 2008. Harrison's Principles of Internal Medicine. 17th ed. McGraw-Hill, New York, N.Y. Vol. 1, pp. 644–645.
13. Green, R. 2008. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr. Bull. 29(Suppl.): S52–S63. PMID:18709881.
14. Green, R. 1995. Metabolite assays in cobalamin and folate deficiency. Baillieres Clin. Haematol. 8: 533–566. doi:10.1016/S0950-3536(05)80220-3. PMID:8534961.
15. Green, R. 2010. Folate, cobalamin, and megaloblastic anemias. In Williams hematology. 8th ed. Edited by K. Kaushansky, E. Beutler, U. Seligsohn, M.A. Lichtman, T.J. Kipps, and J.T. Prchal. McGraw-Hill, New York, N.Y. pp. 533–563.
16. Hoffmann, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., and McGlave, P. (Editors). 2005. Hematology: Basic Principles and Practice. 4th ed. Elsevier. pp. 528–529.
17. Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke. JAMA, 288: 2015–2022. doi:10.1001/jama.288.16. 2015. PMID:12387654.
18. Joosten, E., van den Berg, A., Riezler, R., Naurath, H.J., Lindenbaum, J., Stabler, S.P., et al. 1993. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am. J. Clin. Nutr. 58(4): 468–476. PMID:8037789.
19. Khanduri, U., and Sharma, A. 2007. Megaloblastic anaemia: prevalence and caus ative factors. Natl. Med. J. India, 20(4): 172–175. PMID:18085121.
20. Khanduri, U., Sharma, A., and Joshi, A. 2005. Occult cobalamin and folate defi- ciency in Indians. Natl. Med. J. India, 18(4): 182–183. PMID:16252546.
21. Lee, G.R. 1993. Megaloblastic and nonmegaloblastic changes in macrocytic anae-mias. In Clinical Hematology. Edited by G.R. Lee. Lea & Fabiger, Philadelphia, Pa. Vol. 1, pp. 745–790.
22. Lindentaum, J., and Nath, B.J. 1980. Megaloblastic anaemia and neutrophil hy-persegmentation. Br. J. Haematol. 44: 511–513. doi:10.1111/j.1365-2141.1980. tb05922.x. PMID:7378314.
23. Lindgren, A., Kilander, A., Bagge, A., and Nexo, E. 1999. Holotranscobalamin — a sensitive marker of cobalamin malabsorption. Eur. J. Clin. Invest. 29: 321–329. doi:10.1046/j.1365-2362.1999.00446.x. PMID:10231344.
24. Metz, J., Bell, A.H., Flicker, L., Bottiglieri, T., Ibrahim, J., Seal, E., et al. 1996. The significance of subnormal serum vitamin B12, concentration in older people: a case control study. J. Am. Geriatr. Soc. 44: 1355–1361. PMID:8909352.
25. Obeid, R., McCaddon, A., and Herrmann, W. 2007. The role of hyperhomocys-teinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med. 45(12): 1590–1606. doi:10.1515/CCLM.2007.356. PMID: 18067446.
26. Refsum, H., Yajnik, C.S., Gadkari, M., Schneede, J., and Vollset, S.E. 2001. Hyper-homocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am. J. Clin. Nutr. 74: 233–241. PMID:11470726.
27. Selhub, J., Jacques, P.F., Bostom, A.G., D'Agostino, R.B., Wilson, P.W., Belanger, A.J., et al. 1995. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332: 286–291. doi:10.1056/NEJM199502023320502. PMID:7816063.
28. Spence, J.D. 2006. Nutrition and stroke prevention. Stroke, 37: 2430–2435. doi: 10.1161/01.STR.0000236633.40160.ee. PMID:16873712.
29. Thompson, W.G., Cassino, C., Babitz, L., Meola, T., Berman, R., Lipkin, M., Jr., and Freedman, M. 1989. Hypersegmented neutrophils and vitamin B12 deficiency. Acta Haematol. 81: 186–191. doi:10.1159/000205559. PMID:2502892.
30. Undas, A., Brozek, J., and Szczeklik, A. 2005. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb. Haemost. 94(5): 907–915. doi:10.1160/TH05-05-0313. PMID:16363230.
31. Vogiatzoglou, A., Oulhaj, A., Smith, A.D., Nurk, E., Drevon, C.A., Ueland, P.M., et al. 2009a. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 55: 2198–2206. doi:10.1373/clinchem.2009.128678. PMID:19833840.
32. Vogiatzoglou, A., Smith, A.D., Nurk, E., Berstad, P., Drevon, C.A., Ueland, P.M., et al. 2009b. Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homo-cysteine Study. Am. J. Clin. Nutr. 89(4): 1078–1087. doi:10.3945/ajcn.2008. 26598. PMID:19190073.
33. Wald, D.S., Law, M., and Morris, J.K. 2002. Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. Br. Med. J. 325: 1202–1208. doi:10.1136/bmj.325.7374.1202. PMID:12446535.
34. Wallerstein, R.O. 1987. Laboratory evaluation of anaemia. West. J. Med. 443–451. PMID:3577135.
35. Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, V., et al. 2007. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 369: 1876–1882. doi:10.1016/S0140-6736(07)60854-X. PMID:17544768.
36. Wang, T.C., Jia, G., Zhang, J., Ma, V.H., Liu, L.Z., Zhang, N., et al. 2011. Vitamin B12 and folate deficiency and elevated plasma total homocysteine in workers with chronic exposure to chromate. Occup. Environ. Med. 68: 870–875. doi: 10.1136/oem.2010.063305. PMID:21508429.
37. Wickramasinghe, S.N., and Ratnayaka, I.D. 1996. Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocyto-sis. J. Clin. Pathol. 49: 755–758. doi:10.1136/jcp.49.9.755. PMID:9038761.
38. Yajnik, C.S., Deshpande, S.S., Lubree, H.G., Naik, S.S., Bhat, D.S., Uradey, B.S., et al. 2006. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J. Assoc. Physicians India, 54: 775–782. PMID:17214273.
39. Yang, Q., Botto, L.D., Erickson, J.D., Berry, R.J., Sambell, C., Johansen, H., et al. 2006. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation, 113: 1335–1343. doi:10.1161/CIRCULATIONAHA.105. 570846. PMID:16534029.